(Q43899644)

27 November 2017

title

(18)F-FDG-PET/CT predicts early tumor recurrence in living donor liver transplantation for hepatocellular carcinoma (English)

1 reference

27 November 2017

main subject

liver transplantation

1 reference

Seung Duk Lee

1

1 reference

27 November 2017

Seong Hoon Kim

2

1 reference

27 November 2017

Young-Kyu Kim

3

1 reference

27 November 2017

Chulhan Kim

4

1 reference

27 November 2017

Seok-Ki Kim

5

1 reference

27 November 2017

Sung-Sik Han

6

1 reference

27 November 2017

Sang-Jae Park

7

1 reference

27 November 2017

publication date

25 October 2012

1 reference

27 November 2017

number of pages

11

1 reference

based on heuristic

inferred from page(s)

published in

Transplant International

1 reference

27 November 2017

volume

26

1 reference

27 November 2017

issue

1

1 reference

27 November 2017

page(s)

50-60

1 reference

The evolution of liver transplantation for hepatocellular carcinoma (past, present, and future).

27 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2012.01572.X

Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2012.01572.X

Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2012.01572.X

Living-donor liver transplantation: 12 years of experience in Asia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2012.01572.X

Reassessing selection criteria prior to liver transplantation for hepatocellular carcinoma utilizing the Scientific Registry of Transplant Recipients database

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2012.01572.X

Treatment of HCC in patients awaiting liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2012.01572.X

Prediction of tumor recurrence by 18F-FDG PET in liver transplantation for hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2012.01572.X

18F-FDG-uptake of hepatocellular carcinoma on PET predicts microvascular tumor invasion in liver transplant patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2012.01572.X

The value of positron emission tomography (PET) imaging in disease staging and therapy assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2012.01572.X

Learning curve for living-donor liver transplantation in a fledgling cancer center.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2012.01572.X

Diagnostic imaging of hepatocellular carcinoma in patients with cirrhosis before liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2012.01572.X

Liver transplantation for hepatocellular carcinoma in cirrhosis: is clinical tumor classification before transplantation realistic?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2012.01572.X

The role of (18)F-FDG-PET imaging for the selection of liver transplantation candidates among hepatocellular carcinoma patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2012.01572.X

FDG PET/CT imaging to rule out extrahepatic metastases before liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2012.01572.X

18F-FDG PET in the detection of extrahepatic metastases from hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2012.01572.X

Usefulness of positron emission tomography with fluorine-18-fluorodeoxyglucose for predicting outcome in patients with hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2012.01572.X

Vascular invasion and histopathologic grading determine outcome after liver transplantation for hepatocellular carcinoma in cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2012.01572.X

Alpha-fetoprotein and novel tumor biomarkers as predictors of hepatocellular carcinoma recurrence after surgery: a brilliant star raises again

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2012.01572.X

Living donor liver transplantation for early hepatocellular carcinoma: A life-expectancy and cost-effectiveness perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2012.01572.X

10.1111/J.1432-2277.2012.01572.X

21 January 2018

Identifiers

DOI

1 reference

27 November 2017

1 reference